Variant report
Variant | nsv508346 |
---|---|
Chromosome Location | chr5:8249498-8275350 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146012539 | chr5:8254225-8254226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs575576288 | chr5:8254251-8254252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs538229248 | chr5:8254292-8254293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569280833 | chr5:8254307-8254308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536748222 | chr5:8254311-8254312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs73739505 | chr5:8254364-8254365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs180921321 | chr5:8254390-8254391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs139898670 | chr5:8254403-8254404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs574019871 | chr5:8254409-8254410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs542944110 | chr5:8254421-8254422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563183668 | chr5:8254422-8254423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs531246782 | chr5:8254477-8254478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs185193397 | chr5:8254488-8254489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs191289596 | chr5:8254551-8254552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs527338592 | chr5:8254595-8254596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs7721147 | chr5:8254598-8254599 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs142043553 | chr5:8254618-8254619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs372840369 | chr5:8254620-8254621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs181234136 | chr5:8254697-8254698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs534796931 | chr5:8254706-8254707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs186935924 | chr5:8254723-8254724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553340848 | chr5:8254770-8254771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs73739506 | chr5:8254771-8254772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs191824472 | chr5:8254801-8254802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs571426524 | chr5:8254828-8254829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs113010632 | chr5:8254863-8254864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs374842178 | chr5:8254958-8254959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs367654629 | chr5:8254960-8254961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs150843851 | chr5:8254975-8254976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs373006217 | chr5:8254979-8254980 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs182721469 | chr5:8255021-8255022 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs74724449 | chr5:8255037-8255038 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs376442362 | chr5:8255086-8255087 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542119651 | chr5:8255100-8255101 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561271242 | chr5:8255116-8255117 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs556628779 | chr5:8255142-8255143 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs576627091 | chr5:8255157-8255158 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs544684781 | chr5:8255192-8255193 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs35313887 | chr5:8255194-8255195 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs190785393 | chr5:8255251-8255252 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs368836643 | chr5:8255252-8255253 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs576346917 | chr5:8255272-8255273 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs139262491 | chr5:8255291-8255292 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs149992768 | chr5:8255303-8255304 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs145191829 | chr5:8255313-8255314 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs12653137 | chr5:8255344-8255345 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs376831981 | chr5:8255345-8255346 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs569861895 | chr5:8255393-8255394 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs369209072 | chr5:8255462-8255463 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs372261081 | chr5:8255466-8255467 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Cancer | 22183965 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cri-du chat syndrome | 16773131 | CNVD |
Cryptorchidism | 21048976 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Cervical cancer | 16585170 | CNVD |
Mental retardation | 16773131 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Cri-du chat syndrome | 22470819 | CNVD |
sporadic birth defects | 19047251 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:8254200-8254800 | Enhancers | Fetal Kidney | kidney |
2 | chr5:8254600-8255400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr5:8255000-8255600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr5:8255000-8258600 | Weak transcription | Psoas Muscle | Psoas |
5 | chr5:8258800-8259400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr5:8258800-8259400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr5:8258800-8259600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr5:8258800-8259800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |